Related Experiment Video
Updated: Apr 16, 2026
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Optimal drug prediction from personal genomics profiles
Abstract:
Cancer patients often show heterogeneous drug responses such that only a small subset of patients is sensitive to a given anticancer drug. With the availability of large-scale genomic profiling via next-generation sequencing, it is now economically feasible to profile the whole transcriptome and genome of individual patients in order to identify their unique genetic mutations and differentially expressed genes, which are believed to be responsible for heterogeneous drug responses. Although subtyping analysis has identified patient subgroups sharing common biomarkers, there is no effective method to predict the drug response of individual patients precisely and reliably. Herein, we propose a novel computational algorithm to predict the drug response of individual patients based on personal genomic profiles, as well as pharmacogenomic and drug sensitivity data. Specifically, more than 600 cancer cell lines (viewed as individual patients) across over 50 types of cancers and their responses to 75 drugs were obtained from the genomics of drug sensitivity in cancer database. The drug-specific sensitivity signatures were determined from the changes in genomic profiles of individual cell lines in response to a specific drug. The optimal drugs for individual cell lines were predicted by integrating the votes from other cell lines. The experimental results show that the proposed drug prediction algorithm can be used to improve greatly the reliability of finding optimal drugs for individual patients and will, thus, form a key component in the precision medicine infrastructure for oncology care.
Insights
This study introduces a new computational algorithm to predict individual anticancer drug responses using genomic profiles. This approach enhances the reliability of selecting optimal treatments for cancer patients, advancing precision medicine.
Area of Science:
- Computational biology
- Genomics
- Pharmacogenomics
Background:
- Cancer patients exhibit diverse responses to anticancer drugs, with only a subset showing sensitivity.
- Genomic profiling (whole transcriptome and genome) via next-generation sequencing is feasible for identifying genetic variations linked to drug response heterogeneity.
- Current subtyping analyses identify patient subgroups but lack precise individual drug response prediction methods.
Purpose of the Study:
- To develop a novel computational algorithm for predicting individual patient drug response.
- To leverage personal genomic profiles, pharmacogenomic, and drug sensitivity data for accurate prediction.
- To enhance the reliability of identifying optimal anticancer drugs for individual cancer patients.
Main Methods:
- Utilized data from the Genomics of Drug Sensitivity in Cancer database, including over 600 cancer cell lines and responses to 75 drugs.
- Determined drug-specific sensitivity signatures from genomic profile changes in response to specific drugs.
- Predicted optimal drugs for individual cell lines by integrating voting from other cell lines.
Main Results:
- The developed drug prediction algorithm significantly improves the reliability of identifying optimal drugs for individual patients.
- Demonstrated the algorithm's capability to predict drug responses based on personal genomic data.
- The approach shows promise for integration into precision medicine frameworks.
Conclusions:
- The proposed computational algorithm offers a reliable method for predicting individual anticancer drug responses.
- This tool is a key component for advancing precision medicine in oncology care.
- Personalized genomic profiles combined with this algorithm can guide optimal drug selection for cancer patients.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
01:29Pharmacogenetics and Pharmacogenomics: Overview
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
01:27Pharmacogenetics of Drug Metabolism: Overview
01:27Principles of Pharmacogenetics: Types of Genetic Variants
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...